Skip to main contentSkip to breadcrumbsSkip to sub navSkip to doormat

News and Media

Current news and developments from the IMP. For frequent updates, also consider following us on our social media channels, such as Twitter ("X") or LinkedIn

11 Jul 2017

Targeting cancer cells through synthetic lethality

A collaborative study drawing from two IMP labs and led by IMP-alumnus Mark Petronczki, now at Boehringer Ingelheim RCV, demonstrates a unique...
23 Jun 2017

How brains surrender to sleep

Scientists at the Research Institute of Molecular Pathology (IMP) in Vienna study fundamental aspects of sleep in roundworms. Using advanced...
21 Jun 2017

Cancer research icon William G. Kaelin to give Max Birnstiel Lecture

The IMP - Research Institute of Molecular Pathology - cordially invites to the talk "The VHL Tumor Suppressor Protein: Insights into Oxygen Sensing,...
19 Jun 2017

Andrea Pauli awarded FWF START Grant

IMP group leader Andrea Pauli is awarded a START Grant by the Austrian Federal Ministry for Science. She will use the funds of 1.2 Million Euros over...
15 Jun 2017

IMP Scientist Elly Tanaka elected EMBO member

The European Molecular Biology Organisation (EMBO) announced today that 65 distinguished scientists were newly elected to its membership, including...
26 May 2017

12th Microsymposium on Small RNAs at the Vienna BioCenter

The “12th Microsymposium on Small RNAs” has started at the Vienna BioCenter (VBC) today....
22 May 2017

Computational and systems biologist Aviv Regev to give Max Birnstiel Lecture

The IMP - Research Institute of Molecular Pathology - cordially invites to the talk: “Reconstructing Intra- and Inter-Cellular Circuits with Single...
16 May 2017

Impressions of the IMP opening online

Videos and photos of the opening ceremony and party from 1st March are now available online. For guests, they provide an opportunity to refresh their...
15 May 2017

Researchers develop a ‘molecular needle’ using a simplified biological system

IMP-IMBA Group Leader and CSSB scientist Thomas Marlovits and collaborators from MIT discovered that a minimalist approach can also be applied to...
09 May 2017

Manuel Zimmer selected HHMI-Wellcome International Research Scholar

Neuroscientist Manuel Zimmer, a group leader at the Research Institute of Molecular Pathology (IMP) in Vienna, has been selected as HHMI-Wellcome...